The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 3981-3986

  Vairaktaris, Eleftherios ^a   Serefoglou, Zoe ^a   Yapijakis, Christos ^a   Stathopoulos, Panagiotis ^a   Vassiliou, Stavros ^a   Derka, Spyridoula ^a   Nkenke, Emeka ^b   Vylliotis, Antonis ^a   Ragos, Vasilios ^a   Neukam, Friedrich W ^b   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Inflammation; Interleukin 1 beta; Oral cancer; Polymorphism; Thrombophilia

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRINKING BEHAVIOR; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOUTH CANCER; PRIORITY JOURNAL; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 35648939831     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Massano J, Regateiro FS, Januário G, Ferreira A and Portugal C: Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg Oral Med Path Oral Radiol Endod 102(1): 67-76, 2006.
2. Williams HK: Molecular pathogenesis of oral squamous carcinoma. J Clin Pathol 53: 165- 172, 2000.
3. Song, C Xing D, Tan W, Wei Q and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61: 3272-3275, 2001.
4. Vairaktaris E, Yapijakis C, Wiltfang J, Ries J, Vylliotis A, Vasileiou S, Derka S and Neukam FW: Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25: 2561-2566, 2005.
5. Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, Nkenke E, Vylliotis A, Wiltfang J, Avgoustidis D, Critselis E and Neukman FW: The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33: 504-507, 2007.
6. Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukman FW: Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42: 888-892, 2006.
7. Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, Yannopoulos A, Tesseromatis C, Neukam FW and Patsouris E: Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 27(1A): 459-464, 2007.
8. Vairaktaris E, Yiannopoulos A, Vylliotis A, Yapijakis C, Derka S, Vassiliou S, Nkenke E, Serefoglou Z, Ragos V, Papageorgiou G, Vorris E, Critseli E, Avgoustidis D, Neukam F and Patsouris E: Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk for oral cancer. Int J Biol Markers 21(4): 246-250, 2006.
9. Yapijakis C, Vairaktaris E, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Kessler P, Derka S, Vassiliou S, Neukam F and Patsouris E: Association of tumor necrosis factor alpha -308G/A and beta 252G/A polymorphisms with increased risk for oral cancer. Int J Biol Markers, 2006, in press.
10. Tsai CC, Chen CC, Lin CC, Chen CH, Lin TS and Shieh TY: Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues. Kaohsiung J Med Sci 15: 513-519, 1999 [in Chinese].
11. Lytvyn OI, Kopitsa MP and Petyunina OV: Interaction between inflammation and thrombosis in acute coronary syndrome. Kardiol Pol 61: 110-116, 2004 [in Polish and English].
12. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS and Gimbrone MA: Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160(2): 618-623, 1984.
13. Osnes LT, Westvik AB, Joo GB, Okkenhaug C and Kierulf P: Inhibition of IL-I induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL- 10, and IL-13. Cytokine 8: 822-827, 1996.
14. Carmeliet P: Mechanisms of angiogenesus and arteriogenesis. Nature Med 6: 389-395, 2000.
15. Didier N, Romero IA, Creminon C, Wijkhuisen A, Grassi J and Mabondzo A: Secretion of interleukin-1 beta by astrocytes mediates endothelin-I and tumor necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J Neurochem 86: 246-254, 2003.
16. Puhlmann M, Weinreich DM, Farma JM, Carroll NM, Turner EM and Alexander HR: Interleukin-1 beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity. J Transl Med 3: 37, 2005.
17. Hildebrand F, Pape HC and Krettek C: The importance of cytokines in the posttraumatic inflammatory reaction. Unfallchirurg 108: 793-794, 796-803, 2005.
18. Akagi Y, Li u W, Xie K, Zebrowski B, Shaheen RM and Ellis LM: Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1 beta. Br J Cancer 80: 1506-1511, 1999.
19. Naworth PP, Handley DA, Esmon CT and Stern DM: Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83: 3460-3464, 1986.
20. Jablonska E, Piotrowski L and Grabowska Z: Serum Levels of IL-1b, IL-6, TNF-α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 3: 126-129, 1997.
21. Barak V, Kalickman I, Nisman B, Farbstein H, Fridlender ZG, Baider L, Kaplan A, Stephanos S and Peretz T: Changes in cytokine production of breast cancer patients treated with interferons. Cytokine 10: 977-983, 1998.
22. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA and Fearon KC: Elevated tumour interleukin-1 beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 95: 1568-1575, 2006.
23. Macri A, Versaci A, Loddo S, Scuderi G, Travagliante M, Trimarchi G, Teti D and Famulari C: Serum levels of interleukin 1 beta, interleukin 8 and tumor necrosis factor alpha as markers of gastric cancer. Biomarkers 11: 184-193, 2006.
24. Haukim N, Bidwell JL, Smith AJ, Keen LJ, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C and D'Alfonso S: Cytokine gene polymorphism in human disease: on-line databases, supplement 2 Genes Immun 3: 313-330, 2002.
25. El Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G and Martin M: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
26. Pociot F, Molvig J, Wogensen L, Worsaae H and Nerup J: A Taq I polymorphism in the human interleukin-1 beta (1L-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22: 396-402, 1992.
27. Barber MD, Powell JJ, Lynch SF, Fearon KC and Ross JA: A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83: 1443-1447, 2000.
28. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S and Uchikoshi T: Genetic polymorphisms of interleukin-1β in association with the development of alcoholic liver disease in Japanese patients. Am J Gastrenterol 95: 1305-1311, 2000.
29. Kaijzel EL, Dongen H, Bakker AM, Breedveld FC, Huizinga TWJ and Verweij CL: Relationship of polymorphisms of the interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis. Tissue Antigens 59: 122-126, 2002.
30. Palli D, Saieva C, Luzzi I, Masala G, Topa S, Sera F, Gemma S, Zanna I, Errico MD, Zini E, Guidotti S, Valeri A, Fabbrucci P, Moretti R, Testai E, Giudice G, Ottini L, Matullo G, Dogliotti E and Gomez-Miguel MJ: Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 100: 1941-1948, 2005.
31. Sakuma K, Uozaki H, Chong JM, Hironaka M, Sudo M, Ushiku T, Nagai H and Fukayama M: Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1 beta gene polymorphism (+3953*T) and Epstein-Barr virus infection. Int J Cancer 20: 93-97, 2005.
32. Tsai MH, Chen WC, Tsai CH, Hang LW and Tsai FJ: Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal 19: 93-98, 2005.
33. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Sung MN and Sung JJ: Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Int J GastrHepat 52: 1684-1489, 2003.
34. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S and Chouchane L: Genetic variation in pro-inflammatory cytokines (interleukin-1 beta, interleukin-1 alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw 16(4): 253-260, 2005.
35. Sundelin K, Roberg K, Grenman R and Hakansson L: Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro. Acta Otolaryngol 125: 765-773, 2005.
36. Kishimoto T, Akira S and Narazaki M: Interleukin-6 family of cytokines and gp 130. Blood 86(4): 1243-1254, 1995.